Effects of Disease

Effects of disease on the physiology of the growing plant. Edited by P.G. Ayres... 

Monitor the patient for efficacy and adverse effects of disease-modifying and symptomatic therapies every... 

L. Z. Benet, A. Greither, and W. Meister, Gastrointestinal absorption of drugs in patients with cardiac failure, in The Effect of Disease States on Drug Pharmacokinetics (L. Z. Benet, ed.), Academy of Pharmaceutical Association, Washington, D.C, 1976, pp. 33-50. 

Effects of diseases on crop yield and quality in organic systems... 

Predict binding sites for drug interactions and modulations of causative effects of disease pathway. 

Over the years, we have learned a great deal about the functions of each of these structures. This knowledge has come about in several ways. First, we can look at the effect of disease or injury in a particular part of the brain. For example, if a stroke causes paralysis, then we can assume that the injured part of the brain was responsible for movement of the paralyzed body parts. Likewise, if an injury results in certain personality changes, then we can assume that the injured part of the brain contributed to those behavioral alterations. One of the best-known examples is the effect of a stroke upon mood. It is well known that a stroke to the left frontal area of the brain dramatically increases the likelihood of depression. On the other hand. 

In addition to the greater risk in patients, results in patients are frequently confounded by the effects of disease, concomitant medication, age and other variables. By contrast, healthy subjects are much more homogeneous and subjects are studied under standardised conditions. It is sometimes argued that healthy volunteers are not representative of the patient population and therefore that the studies are of less... 

A rich library of tracers exists for the dopamine Systran and perhaps also the serotonin system however, little or nothing currently exists for the assessment of many other neurotransmitter systems in the brain, some of whose receptors have been identified only recently. Pharmaceutical and biotechnology industries are major sources not only of new compounds that target these sites as candidate therapeutics but also of compounds that may serve as radiotracers to evaluate these sites and the effects of disease and treatment. The incentive and raw materials for continued development of functional imaging of the human bram will depend on the establishment of sustained collaborations between academic and government research centers and the pharmaceutical industry. 

The basic principles outlined above can be applied to the interpretation of clinical drug concentration measurements on the basis of three major pharmacokinetic variables absorption, clearance, and volume of distribution (and the derived variable, half-life) and two pharmacodynamic variables maximum effect attainable in the target tissue and the sensitivity of the tissue to the drug. Diseases may modify all of these parameters, and the ability to predict the effect of disease states on pharmacokinetic parameters is important in properly adjusting dosage in such cases. (See The Target Concentration Strategy.)... 

Ayres, P.G., Paul, N.D. The effects of disease on interspecific plant competition. Aspects of Appl Biol 1990 24 155-162. 

Jarosz, A.M., Davelos, A.L. Effects of disease in wild plant populations and the evolution of pathogens aggressiveness. New Phytol 1995 129 371-387. 

M.J.M. Wijnands, and P.L.C.M. Van Riel, Management of adverse effects of disease modifying anti-rheumatic drugs. Drugs Saftey 13 219-227, 1995. 

Simpson MD, Slater P, Royston MC, Deakin JF. 1991. Alterations in phencyclidine and sigma binding sites in schizophrenic brains. Effects of disease process and neuroleptic medication. Schizophr Res 6 41-48. 

Friend, J. In Effects of Disease on the Physiology of the Growing Plant Ayres, P.G. Ed. Cambridge University Press New York, 1981 pp. 179-200... 

One obstacle when studying dopamine receptors in schizophrenic subjects, is that most schizophrenics have been treated with antipsychotic agents, all of which block D2 and D3 receptors, and many also block D4 dopamine receptors. Thus, it can be difficult to dissociate effects specific to the disease from the effects of disease treatment. This is an... 

Several groups have found that some incUviduals have titers of antibodies against the AB peptide. Unfortunately, consensus regarding a relationship to Alzheimer s disease has not yet emerged as there are reports of increased titers with disease (Nath et al., 2003), decreased titers with disease (Weksler et al., 2002) or no effect of disease (Hyman et al., 2001). It should be noted that the antibody titers observed are exfiremely low compared to those observed after immunization. Moreover, it is not clear the degree to which endogenous AB may interfere with the detection of anti-AB antibodies by ELISA (see Li et al., 2004). 

The wide variety of morphological, physiological, and biochemical information available from the multitude of MR techniques, which allow sophisticated combinations of methods to be applied to individual neurological studies. This is one reason that MRI is often the best choice for neuroimaging studies, as the combination of multiple methods in one study can provide a wide array of coregistered information on the effects of disease and experimental therapies on brain function and biochemistry. 

In 1855, Dr Thomas Addison, assisted in his observations by three colleagues, published his famous monograph On the constitutional effects of disease on the suprarenal capsules (Addison s disease). It was not until the late 1920s that the vital importance of the adrenal cortex was appreciated and the distinction between the hormones secreted by the cortex and medulla. 

---